DEPUY ACE TIMAX META PLATE
K983853 · Depuy Ace Medical Co. · HRS · Dec 22, 1998 · Orthopedic
Device Facts
| Record ID | K983853 |
| Device Name | DEPUY ACE TIMAX META PLATE |
| Applicant | Depuy Ace Medical Co. |
| Product Code | HRS · Orthopedic |
| Decision Date | Dec 22, 1998 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 888.3030 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
Distal intra-articular tibia fractures Proximal tibia fractures Proximal and distal humerus fractures
Device Story
The DePuy ACE TiMAX™ Meta Plate is a metallic bone fixation appliance designed for orthopedic surgery. It features a triangular metaphyseal projection and a shaft with compression slots (13mm pitch). The plate thickness varies from 1.6mm in the shaft to 1.0mm in the metaphyseal region. A central cut-out in the metaphyseal area allows for surgeon contouring to match anatomical topography and promotes fracture healing. The device accommodates 3.5mm cortical and 4.0mm cancellous screws. It is available in small (30mm width) and large (38mm width) sizes. Used by orthopedic surgeons in clinical settings to stabilize fractures, the plate provides mechanical support to facilitate bone healing.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Metallic bone fixation plate. Features triangular metaphyseal projection and compression slots. Thickness: 1.6mm (shaft) to 1.0mm (metaphyseal). Compatible with 3.5mm cortical and 4.0mm cancellous screws. Available in two widths (30mm, 38mm).
Indications for Use
Indicated for patients with distal intra-articular tibia fractures, proximal tibia fractures, and proximal or distal humerus fractures.
Regulatory Classification
Identification
Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.
Predicate Devices
- Synthes Cloverleaf Plate, P/N 240.23
Related Devices
- K990120 — MODIFICATION OF DEPUY ACE TIMAX MEDIAL PILON PLATE · Depuy Ace Medical Co. · Feb 1, 1999
- K982347 — DEPUY ACE TIMAX PILON PLATE · Depuy Ace Medical Co. · Aug 31, 1998
- K981775 — DEPUY ACE TIMAX CALCANEAL PERI-ARTICULAR PLATE · Depuy Ace Medical Co. · Jul 29, 1998
- K001945 — SYNTHES (USA) MEDIAL DISTAL TIBIA PLATES · Synthes (Usa) · Sep 22, 2000
- K011978 — SYNTHES LCP PROXIMAL TIBIA PLATE · Synthes (Usa) · Aug 9, 2001
Submission Summary (Full Text)
{0}------------------------------------------------
6 4 8 3 8 5 3
್ನಾ
# DEC 2 2 1998
# 510(k) SUMMARY
NAME OF FIRM:
510(k) CONTACT PERSON:
TRADE NAME:
COMMON NAME:
CLASSIFICATION NAME:
REGULATORY CLASS:
DEVICE CODE:
SUBSTANTIALLY EQUIVALENT DEVICES: DePuy ACE Medical Company 2260 East El Segundo Boulevard El Segundo, CA 90245
Kathleen Dragovich Regulatory Affairs Specialist DePuy ACE Medical Company
DePuy ACE TiMAX™ Meta Plate
Plate, Fixation, Bone
888.3030 Single/multiple component metallic bone fixation appliances and accessories.
Class II
87HRS
Synthes Cloverleaf Plate, P/N 240.23
#### INTENDED USE:
- I Distal intra-articular tibia fractures
- 트 Proximal tibia fractures
- 내 Proximal and distal humerus fractures
### DEVICE DESCRIPTION AND SUBSTANTIAL EQUIVALENCE RATIONALES:
The DePuy ACE TiMAX™ Meta Plate has a triangular shaped projection at the end of a shaft portion. The shaft portion has compression slots with a pitch of 13mm which matches the small fragment, active compression plate. The plate thickness is 1.6mm in the shaft region and transitions to a thickness of 1mm in the triangular shaped metaphyseal region. A cut-out in the middle of the metaphyseal region provides an open architecture to facilitate contouring by the surgeon, to accommodate the anatomical topography of the distal tibia as well as other indicated anatomical regions, and also to promote fracture healing. The screw holes have been designed to allow low profile interaction with the heads of the 3.5mm cortical screw and the 4.0mm cancellous screw. The plate will be offered in two sizes: small (width=30mm) and large (width=38mm) with various lengths.
The DePuy ACE TiMAX™ Meta Plate is similar in design and function to the Synthes Cloverleaf plate (pre-amendment device).
{1}------------------------------------------------
Image /page/1/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, with three intertwined lines representing the branches of government and a stylized human figure at the top.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 22 1998
Mr. Paul Doner Director, Regulatory and Clinical Affairs DePuy ACE Medical Company 2260 East El Segundo Boulevard El Segundo, California 90245-4694
K983853 Re: DePuy ACE TiMAX™ Meta Plate Regulatory Class: II Product Code: HRS Dated: October 27, 1998 Received: October 30, 1998
Dear Mr. Doner:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. ਰ substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Requlation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
{2}------------------------------------------------
Page 2 - Mr. Paul Doner
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
-Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for DePuy ACE. The logo consists of a black circle followed by the text "DePuyACE" in a stylized font. The letters are all capitalized, and the "ACE" portion is slightly smaller than the "DePuy" portion. There is a trademark symbol in the bottom right corner of the logo.
510(k) Number (if known) _ K 983853
DePuy ACE TiMAX™ Meta Plate Device Name:
Indication for User:
- Distal intra-articular tibia fractures 買
- Proximal tibia fractures 포
- Proximal and distal humerus fractures E
Concurrence of CDRH, Office of Device Evaluation
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter
locottefa
(Division Sign-Off) Division of General Restorative i 510(k) Number _